期刊文献+

肺癌相关内源性激素及其受体研究进展 被引量:1

Research Progress of Lung Cancer Related to Endogenous Hormone and its Receptor
原文传递
导出
摘要 查阅近年来有关肺癌相关内源性激素及其受体研究的文献,将整理与肺癌密切相关的几种内源性多肽类激素如血管紧张素及其受体、雌激素及其受体、胰岛素样生长因子及其受体、生长抑素及其受体与胸腺激素等进行综合分析。结果显示调节肺癌的发生和发展与内源性激素调节紊乱有一定的关系,血管紧张素及其受体、雌激素及其受体、胰岛素样生长因子及其受体、生长抑素及其受体、胸腺激素均有抑制肺癌生长的作用。寻找和设计抗肺癌药物乃至抗肿瘤药物,内源性寡肽类激素及其类似物将是一个重要的考虑方向。研究与肺癌发生和发展相关的内源性激素及其调控网络,对于设计和研发抗肺癌药物具有及其重要的参考价值。 This paper reviews recent endogenous small molecule peptide-hormone and its analogues,and the occurrence of lung cancer and the development of relations involved in the mediation of the body’s physiological and biochemical functions.Traditional cytotoxic anticancer drugs in lung cancer chemotherapy in the treatment of tumors,normal vital organs of the human body and cause serious toxicity in the pathogenesis of lung cancer and the cause has not been fully elucidated,you need to find one within the derived low toxicity,readily biodegradable anticancer drugs,such as small molecule peptide-hormones and their analogues has become the research focus in recent years.Accordingly this article endogenous polypeptide hormone summarized to provide a reference for the latter part of the design and development of anticancer drugs.
出处 《中国实验方剂学杂志》 CAS 北大核心 2013年第15期340-343,共4页 Chinese Journal of Experimental Traditional Medical Formulae
基金 科技部新药重大专项(2011zx09102-001-31) 国家高技术研究发展计划(2012AA020304) 广东省科技计划(2010B031500034) 中山市科技局项目(2009H018) 广东药学院中青年骨干教师专项课题
关键词 肺癌 内源性激素 受体 研究进展 lung cancer endogenous hormones receptor research progress
  • 相关文献

参考文献22

  • 1Rebecca S, Carol D S, Katherine V, et al. Cancer treatment and survivorship statistics, 2012 [ J]. CA CANCER J CLIN, 2012,123:5391.
  • 2Alexsandra F, Marija G, Zeljko F, et al. Lung cancer and environmental chemical exposure: a review of our current state of knowledge with reference to the role of hormones and hormone receptors as an increased risk factor for developing lung cancer in man [ J ]. Toxicologic Pathology, 2012 ( 38 ) : 849.
  • 3Luca P, Nicholas J P, Chadrick E D,et al. A decade of advances in treatment of early-stage lung cancer [ J ]. Clin Chest Med, 2011 (32) :827.
  • 4Pallavi K, Harinder S, Ankur G, et al. Tumor hope: a database of tumor homing peptides [ J ]. PLoS ONE, 2012,4(7) :1.
  • 5Ni L, Feng Y, Wan H Y, et al. Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the pi3k/akt and mapk signaling pathways [ J ]. Oncology Reports, 2012, 27:783.
  • 6Jyotsana M, David R S, Michael F C, et al. Angiotensin-( 1-7 ) inhibits growth of human lung adenocarcinoma senografts in nude mice through a reduction in cyclooxygenase-2 [ J]. Cancer Rese, 2007, 67:2809.
  • 7David R S, Jyotsana M, Patricia E G, et al. Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor[ J]. Mol Cancer Ther, 2009, 8(6) :1676.
  • 8Lara P, Takaya M, Chiyo D, et al. Over-expression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells [ J ]. Cancer Biol Ther, 2011, 9(4):1.
  • 9邵东晖,王秀问.ERα和ERβ在非小细胞肺癌中作用的研究进展[J].中国肿瘤生物治疗杂志,2010,17(2):237-241. 被引量:2
  • 10Drzewiecka H, Jagodzinski P P. Conversion of estrone to 17-beta-estradiol in human non-small-cell lung cancer cells in vitro[ J]. Biomed Pharmacother, 2012, 66(7) : 530.

二级参考文献45

  • 1De Perrot M,Licker M,Bouchardy C,Usel M,Robert J,Spiliopoulos A.Sex differences in presentation,management,and prognosis of patients with non-small cell lung carcinoma[J].Thorac,Cardiovasc Surg,2000,119(1):21-26.
  • 2Mazières J,Rouquette I,Brouchet L.Lung cancer in women and pregnancy:towards a hormonal origin[J]? Rev Mal Respir,2007,24(8):983-997.
  • 3Sica G,Wagner PL,Altorki N,Port J,Lee PC,Vazquez MF,et al.Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors[J].Arch Pathol Lab Med,2008,132(12):1889-1895.
  • 4Ivanova MM,Mazhawidza W,Dougherty SM,Minna JD,Klinge CM.Activity and intracellular location of estrogen receptors alpha and beta in human bronchial epithelial cells[J].Mol Cell Endocrinol,2009,305(1-2):12-21.
  • 5Zhang G,Liu X,Farkas AM,Parwani AV,Lathrop KL,Lenzner D,et al.Estrogen receptor beta functions through nongenomic mechanisms in lung cancer cells[J].Mol Endocrinol,2009,23(2):146-156.
  • 6Hershberger PA,Stabile LP,Kanterewicz B,Rothstein ME,Gubish CT,Land S,et al.Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription,p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells[J].J Steroid Biochem Mol Biol,2009,116(1-2):102-109.
  • 7Hammoud Z,Tan B,Badve S,Bigsby RM.Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma[J].Endocr Relat Cancer,2008,15(2):475-483.
  • 8Mollerup S,Jrgensen K,Berge G,Haugen A.Expression of estrogen receptors alpha and beta in human lung tissue and cell lines[J].Lung Cancer,2002,37(2):153-159.
  • 9Stabile LP,Davis AL,Gubish CT,Hopkins TM,Luketich JD,Christie N,et al.Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen[J].Cancer Res,2002,62(7):2141 -2150.
  • 10Radzikowska E,Langfort R,Giedronowicz D.Estrogen and progesterone receptors in non-small cell lung cancer patients[J].Ann Thorac Cardiovasc Surg,2002,8(2):69-73.

共引文献4

同被引文献14

  • 1Seo J,Park SJ,Kim J,et al.Effective method for the isolation and proliferation of primary lung cancer cells from patient lung tissues[J].Biotechnol Lett,2013,35(8):1165-1174.
  • 2Colonias A,Betler J,Trombetta M,et al.Mature follow-up for highrisk stage I non-small-cell lung carcinoma treated with sublobar resection and intraoperative iodine-125 brachytherapy[J].Int J Radiat Oncol Biol Phys,2011,79(1):105-109.
  • 3Evers PD,Logan JE,Sills V,et al.Karnofsky Performance Status predicts overall survival,cancer-specific survival,and progressionfree survival following radical cystectomy for urothelial carcinoma[J].World J Urol,2014,32(2):385-391.
  • 4Suzuki C,Torkzad MR,Jacobsson H,et al.Interobserver and intraobserver variability in the response evaluation of cancer therapy according to RECIST and WHO-criteria[J].Acta Oncol,2010,49(4):509-514.
  • 5Trombetta MG,Colonias A,Makishi D,et al.Tolerance of the aorta using intraoperative iodine-125 interstitial brachytherapy in cancer of the lung[J].Brachytherapy,2008,7(1):50-54.
  • 6Schmid-Bindert G,Henzler T,Chu TQ,et al.Functional imaging of lung cancer using dual energy CT:How does iodine related attenuation correlate with standardized uptake value of 18FDG-PETCT[J].Eur Radiol,2012,22(1):93-103.
  • 7陈万青,张思维,邹小农.中国肺癌发病死亡的估计和流行趋势研究[J].中国肺癌杂志,2010,13(5):488-493. 被引量:517
  • 8李玮,谭建,龙雷.hTPO和hNIS共转染肺癌细胞系H460介导放射性碘摄取的研究[J].中国肺癌杂志,2010,13(6):575-579. 被引量:1
  • 9罗彬,秦蓁,王旭东.肺癌MMP-9和VEGF表达与微血管密度的关系及其意义[J].现代预防医学,2011,38(7):1338-1339. 被引量:10
  • 10陈志军,周爱清,刘震天,王文俊,吴真.^(125)碘粒子植入联合化疗治疗中晚期肺癌[J].南昌大学学报(医学版),2011,51(8):60-62. 被引量:8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部